Ignite Creation Date:
2025-12-24 @ 9:58 PM
Ignite Modification Date:
2026-04-14 @ 2:04 PM
Study NCT ID:
NCT03161132
Status:
COMPLETED
Last Update Posted:
2023-01-27
First Post:
2017-05-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Resistant Ovarian Cancer, Olaparib and Liposomal Doxorubicin
Sponsor:
Grupo Español de Investigación en Cáncer de Ovario
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-13
Start Date Type:
ACTUAL
Primary Completion Date:
2020-02-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-12-31
Completion Date Type:
ACTUAL
First Submit Date:
2017-05-17
First Submit QC Date:
None
Study First Post Date:
2017-05-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-25
Last Update Post Date:
2023-01-27
Last Update Post Date Type:
ACTUAL